Join Lonza's experts during a scientific program presentation and schedule a meeting to discuss your next project at our virtual booth. 

Celebrating its 10th anniversary, the HPAPI Summit invites to join this year 130+ senior fellow colleagues to benchmark against best practice, and sustainable, safe quality pipeline! Summit will be covering a comprehensive guide to ensure safety and compliance in HPAPI processes. There will be introduced new themes including
  • Safe handling in R&D, prior to toxicological data is available.
  • Environmental impact, product stewardship, and lifecycle management.
  • Continuous manufacturing, automation, and emerging technologies.
  • Uniting containment with first-class facility design to minimize risk.
 
 
We hope you can join us for the following virtual presentation. Mark your calendar!
  
 

Program presentations:

 

Christian Noti

Christian Noti, Development Services & HPAPI Lab Manufacturing

 

In the past 7 years, he has played a significant role in further expanding Lonza’s HPAPI business in the Highly Potent Products Development and Lab Scale Manufacturing team.

Sean Diver

Sean Diver, Director, Commercial Development

 

He has worked across a broad portfolio of technologies in cGMP Chemical & Biological custom manufacturing from early stage to late phase/commercial and gained significant experience with Highly Potent Active Pharmaceutical Ingredients (HPAPI, incl. ADC), and Supply Chain security along the way.

 

Fast speed manufacturing scale expansion of a High Potent Product process – from lab scale to Monoplant within 30 months 

Wednesday, 23 June 2021. 3:30pm - 4:00pm (EDT)
 
About the presentation:
In an extensive case study, the critical success factors enabling successful process implementation, fast manufacturing scale expansion, ergonomic and robust design of a new efficient plant asset applying a mono plant approach are presented for a highly potent product.

Objectives:
  • a robust approach for a strong tech transfer and compliant manufacturing of a very high potent compound
  • parallelization of workstreams enabling parallel process development/characterization, clinical supply, and commercial mono plant asset realization based on a strong and flexible workforce
  • key factors to ensure implementation of a “right first time design” plant
  • importance of strong in house experience for quality and safety, process development, and plant construction capabilities ensuring compliant and efficient manufacturing of a very high potent product


 
 
Meet 1-2-1 with our expert in the virtual event: schedule a session.
 
 

 
Can’t attend the virtual event? Access other relevant technical content in our Knowledge Center


    

Lorem ipsum dolor sit amet